Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Journal
Japanese journal of ophthalmology
Journal Volume
67
Journal Issue
3
Date Issued
2023-05
Author(s)
Shimura, Masahiko
Kitano, Shigehiko
Ogata, Nahoko
Mitamura, Yoshinori
Oh, Hideyasu
Ochi, Haruka
Ohsawa, Shino
Hirakata, Akito
Abstract
To evaluate efficacy, durability, and safety of faricimab in Japanese patients with diabetic macular edema (DME).
Subjects
Angiopoietin-2; Anti-VEGF therapy; Diabetic macular edema; Faricimab; Vascular stability
Type
journal article